Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome

靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能

基本信息

  • 批准号:
    10554383
  • 负责人:
  • 金额:
    $ 59.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-01 至 2026-02-28
  • 项目状态:
    未结题

项目摘要

Summary Sjögren’s syndrome (SS), an autoimmune exocrinopathy of the salivary and lacrimal glands, affects ~ 4 million Americans, 90% of whom are women. SS is characterized by sialadenitis and dacryoadenitis, decreased saliva (i.e., xerostomia) and tear production (i.e., xerophthalmia) and the presence in blood serum of autoantibodies against Ro/SSA and La/SSB. Xerostomia and xerophthalmia in SS patients can lead to periodontitis, yeast and bacterial infections, digestive disorders and vision deterioration that severely reduce the quality of life for patients. Ultimately, chronic inflammation in SS leads to secondary autoimmune diseases, tissue fibrosis and lymphoma. Therapy for SS is limited to symptom management through external hydration, artificial saliva and tears and muscarinic receptor agonists that induce fluid secretion from residual exocrine acinar cells. Such remedies are universally judged to be inadequate and thus, development of more effective SS treatments is essential. Our research focuses on cell surface P2X7 and P2Y2 receptors for extracellular ATP, the intracellular chemical form of energy that when released from damaged salivary glands initiate inflammatory responses. Our studies show that P2X7R and P2Y2R antagonists enhance saliva secretion and reduce lymphocytic foci in salivary glands of two different mouse models of SS. Antagonism of the P2X7R also reduces lymphocytic accumulation in the lacrimal glands and increases tear secretion. These antagonists have not been used to treat human SS, although P2X7R is upregulated in salivary glands of SS patients compared to non-SS controls. P2X7R activation in salivary glands also induces maturation and release of IL-1β, an SS- related cytokine that upregulates P2Y2R in immune and epithelial cells, suggesting that P2X7R and P2Y2R contribute together to SS development. This project will investigate the ability of P2X7R and/or P2Y2R antagonists to increase saliva and/or tear secretion and reduce sialadenitis and/or dacryoadenitis in mouse models of SS. These findings will be validated by assessing P2X7R and P2Y2R expression in archived human SS and control minor salivary gland biopsies and evaluating effects of P2X7R and/or P2Y2R antagonism in freshly isolated human salivary and lacrimal gland cells. Specific Aim 1 will investigate the hypothesis that P2X7R and P2Y2R play sequential roles in chronic sialadenitis and glandular dysfunction in SS mouse models and can be antagonized to treat SS in vivo. Specific Aim 2 will investigate the hypothesis that P2X7R and P2Y2R activation in lacrimal gland epithelial cells promotes dry eye disease in mouse models of SS. Specific Aim 3 will investigate P2X7R and P2Y2R-mediated proinflammatory responses in human primary salivary and lacrimal gland cells and human SS minor salivary gland biopsies. Successful completion of this proposal will represent a critical step towards realization of the ultimate goal of targeting the P2X7R and/or P2Y2R to treat SS in humans.
总结 干燥综合征(SS)是一种唾液腺和泪腺的自身免疫性外分泌病, 美国有100万人,其中90%是女性。SS的特征是涎腺炎和泪腺炎, 唾液减少(即,口干症)和泪液产生(即,干眼症)和血清中的存在 抗Ro/SSA和La/SSB的自身抗体。干燥综合征患者的口干和干眼症可导致 牙周炎,酵母菌和细菌感染,消化系统疾病和视力下降,严重减少 患者的生活质量。最终,SS中的慢性炎症导致继发性自身免疫性疾病, 组织纤维化和淋巴瘤。SS的治疗仅限于通过外部水合作用进行症状管理, 人工唾液和泪液以及毒蕈碱受体激动剂,其诱导液体从残余外分泌分泌 腺泡细胞这种补救办法被普遍认为是不够的,因此,发展更有效的 SS治疗是必要的。我们的研究主要集中在细胞表面P2 X7和P2 Y2受体的细胞外 ATP,细胞内的化学形式的能量,当从受损的唾液腺释放时, 炎症反应。我们的研究表明,P2 X7 R和P2 Y2 R拮抗剂可增强唾液分泌, 减少两种不同SS小鼠模型唾液腺中的淋巴细胞灶。P2 X7 R的拮抗作用也 减少泪腺中的淋巴细胞积聚并增加泪液分泌。这些拮抗剂具有 P2 X7 R在SS患者的唾液腺中上调, 非SS控制。唾液腺中的P2 X7 R激活也诱导IL-1β的成熟和释放, 在免疫和上皮细胞中上调P2 Y2 R的相关细胞因子,表明P2 X7 R和P2 Y2 R 为SS的发展做出贡献。本项目将研究P2 X7 R和/或P2 Y2 R的能力 在小鼠中增加唾液和/或泪液分泌并减轻涎腺炎和/或泪腺炎的拮抗剂 SS模型这些发现将通过评估存档的人类中P2 X7 R和P2 Y2 R的表达来验证。 SS和对照小唾液腺活组织检查,并评估P2 X7 R和/或P2 Y2 R拮抗作用在 新鲜分离的人唾液腺和泪腺细胞。具体目标1将研究假设, P2 X7 R和P2 Y2 R在SS小鼠模型慢性涎腺炎和腺体功能障碍中的顺序作用 并且可以拮抗以在体内治疗SS。具体目标2将研究P2 X7 R和 泪腺上皮细胞中的P2 Y2 R活化促进SS小鼠模型中的干眼症。具体 目的3研究P2 X7 R和P2 Y2 R介导的人原发性唾液腺炎症反应, 泪腺细胞和人SS小唾液腺活检。成功完成此提案将 代表实现靶向P2 X7 R和/或P2 Y2 R以治疗的最终目标的关键一步。 SS在人类

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GARY Andrew WEISMAN其他文献

GARY Andrew WEISMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GARY Andrew WEISMAN', 18)}}的其他基金

The P2X7 receptor for ATP as a therapeutic target in the prevention of radiation-induced salivary gland dysfunction
ATP 的 P2X7 受体作为预防辐射引起的唾液腺功能障碍的治疗靶点
  • 批准号:
    10659723
  • 财政年份:
    2023
  • 资助金额:
    $ 59.46万
  • 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
  • 批准号:
    10685136
  • 财政年份:
    2022
  • 资助金额:
    $ 59.46万
  • 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
  • 批准号:
    10360664
  • 财政年份:
    2021
  • 资助金额:
    $ 59.46万
  • 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
  • 批准号:
    10788973
  • 财政年份:
    2021
  • 资助金额:
    $ 59.46万
  • 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
  • 批准号:
    10219752
  • 财政年份:
    2021
  • 资助金额:
    $ 59.46万
  • 项目类别:
2017 Salivary Glands and Exocrine Biology Gordon Research Conference & Gordon Research Seminar
2017年唾液腺与外分泌生物学戈登研究会议
  • 批准号:
    9248729
  • 财政年份:
    2016
  • 资助金额:
    $ 59.46万
  • 项目类别:
Restoring Salivary Gland Function by Reducing Nucleotide-induced Inflammation
通过减少核苷酸诱导的炎症来恢复唾液腺功能
  • 批准号:
    8630757
  • 财政年份:
    2013
  • 资助金额:
    $ 59.46万
  • 项目类别:
Restoring Salivary Gland Function by Reducing Nucleotide-induced Inflammation
通过减少核苷酸诱导的炎症来恢复唾液腺功能
  • 批准号:
    9185314
  • 财政年份:
    2013
  • 资助金额:
    $ 59.46万
  • 项目类别:
The Regulation of Salivary Gland Regeneration by P2Y2 Nucleotide Receptors
P2Y2核苷酸受体对唾液腺再生的调控
  • 批准号:
    7932509
  • 财政年份:
    2009
  • 资助金额:
    $ 59.46万
  • 项目类别:
CELL, MOLECULAR AND ANIMAL CORE
细胞、分子和动物核心
  • 批准号:
    7192128
  • 财政年份:
    2006
  • 资助金额:
    $ 59.46万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.46万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 59.46万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 59.46万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.46万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 59.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.46万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 59.46万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 59.46万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 59.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 59.46万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了